MYC targeting by OMO-103 in solid tumors: a phase 1 trial.
Explainable machine learning identifies multi-omics signatures of muscle response to spaceflight in mice.
Plasma proteomics discovery of mental health risk biomarkers in adolescents.
Abzu’s Jonas Elsborg presents his research with NASA GeneLab: “Elucidating dermatological changes in spaceflight with explainable AI.”
The TOLAC project brings data-driven insights to expectant parents at important stages of pregnancy to reduce the risk inherent in vaginal or caesarian delivery.
Abzu® selected partner for EU project Elegant North to create a new strategy for handling data on rare diseases.
To address the deficiency of treatments for rare diseases, the selected partners in project Elegant North will create a cross-border, rare disease data-sharing platform to foster cross-sector collaboration between researchers, companies, and healthcare systems.
Quantum lattices for early cancer detection through machine learning.
Predicting inpatient mortality in patients with inflammatory bowel disease: A machine learning approach.
The world’s leading AI-in-medicine summit series. Connecting 200,000 clinicians, technologists, and C-suite executives.
Identifying interactions in omics data for clinical biomarker discovery using symbolic regression.